English | 简体中文 | 繁體中文 | 한국어
Share:
Lubrizol to Increase Its Equity in Lubrizol India Private Limited

News Release

Lubrizol to Increase Its Equity in Lubrizol India Private Limited

CLEVELAND, March 20, 2017 - The Lubrizol Corporation announces its intention to increase its equity in Lubrizol India Private Limited (LIPL), currently a 50-50 joint venture between Lubrizol and Indian Oil Corporation Limited (Indian Oil). Indian Oil has received in-principle approval from the Cabinet Committee on Economic Affairs, chaired by Indian Prime Minister Shri Narenda Modi, to sell part of its ownership stake in the joint venture to Lubrizol. Upon completion of the sale, which is expected to be finalized in a few weeks, Lubrizol will own 74 percent of LIPL and Indian Oil will own 26 percent.

"This action is a step forward for our already strong presence in India across our growing product lines in all market segments. And it allows us to continue to provide the high level of products and service our customers expect from us," says Dan Sheets, president, Lubrizol Additives. "We are also pleased to continue our successful association with Indian Oil as an ongoing partner in the joint venture."

Lubrizol has had a presence in India since 1966, when the company formed a joint venture with the Government of India. The joint venture was later restructured as LIPL with Lubrizol and Indian Oil as partners. LIPL manufactures and markets additive systems for automotive and industrial lubricants, as well as the treatment of fuels.

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It is a leader at combining market insights with chemistry and application capabilities to deliver valuable solutions to customers in the global transportation, industrial and consumer markets. Lubrizol improves lives by acting as an essential partner in our customers' success, delivering efficiency, reliability or wellness to their end users. Technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care, personal care and skin care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 8,300 employees worldwide. Revenues for 2016 were $6.5 billion. For more information, visit Lubrizol.com.

Media Contact
Julie Young
440-347-4432
Website: www.lubrizol.com
###





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook  
Apr 21, 2018 00:30 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 21:33 ET
BOURBON: Positive progress in negotiations with lenders  
Apr 20, 2018 18:30 ET
Hubbell Incorporated Declares Regular Quarterly Dividend  
Apr 20, 2018 16:01 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 15:23 ET
Heineken Holding N.V. - Amendments to the Articles of Association  
Apr 20, 2018 15:18 ET
Lubrizol Presents Estane® TPU and Other Innovations for Consumer, Industrial, Footwear and Electronics Applications at Chinaplas 2018  
Apr 20, 2018 12:03 ET
Lipotec Active Ingredients Becomes Umbrella Brand  
Apr 19, 2018 23:43 ET
LEH PHARMA LTD.: Company Update  
Apr 18, 2018 19:34 ET
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018  
Apr 18, 2018 19:33 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: